Art's-Way Manufacturing Co., Inc. (ARTW) AI Stock Analysis

NASDAQ: ARTWAI research summary: business, growth, valuation, analysts, bull and bear case.

ARTW AI stock analysis summary

AI Research

Art's-Way Manufacturing Co., Inc. (ARTW) manufactures specialized agricultural equipment, modular research buildings, and precision cutting tools. While the company generated $23.0M in FY2025 revenue and posted a net income of $1.0M, trailing twelve-month operations swung to an operating margin of -1.2% and a net loss of -$0.09 per share. The stock has gained 20.3% over the past year, trading at a forward P/E of 6.4x.

Market cap
$16.5M
Revenue (TTM)
$25.2M
P/E
—
fwd 6.4x
1Y return
20.3%
S&P 500 16.8%
Avg. target
$7.00
121.2% vs last close

Bull case

  • The stock is up 34.7% year-to-date and trades at a forward P/E of 6.4x, well below the US-listed Industrials peer median of 17.2x.
  • The analyst mean price target of $7.00 sits 121.2% above the October 16, 2026 closing price of $3.17.
  • Company insiders maintain high alignment with outside investors, holding 61.6% of outstanding shares.

Bear case

  • Cash and short-term investments fell to $2,855 against $6.5M in total debt as of August 31, 2026.
  • Free cash flow remained negative at -$1.5M in FY2025 following an operating cash outflow of -$904,143.
  • Operating performance deteriorated in the quarter ended August 31, 2026, with quarterly revenue dropping 12.7% and earnings sliding 88.5% year-over-year.

What Art's-Way Manufacturing does

Headquartered in Armstrong, Iowa, Art's-Way Manufacturing Co., Inc. designs, manufactures, and distributes agricultural equipment, modular science buildings, and steel cutting tools. The company operates through three segments: Agricultural Products, Modular Buildings, and Tools. Its Agricultural Products segment delivers specialized farm equipment including animal feed processing machinery, hay and forage tools, manure spreaders, sugar beet harvesters, and aftermarket parts. The Modular Buildings segment creates custom containment research laboratories, swine facilities, and academic research units, offering installation and rental services. The Tools segment manufactures carbide-tipped tools, polycrystalline diamond inserts, and OEM precision cutting tools.

Growth and profitability

Over a five-year period from FY2020 to FY2025, revenue grew at a CAGR of 0.5%. Annual revenue reached $30.3M in FY2023 before decreasing to $24.5M in FY2024 and $23.0M in FY2025, when revenue fell 6.2%. FY2025 gross margin was 25.8% and operating margin was 1.3%, though net income rose to $1.0M, or $0.20 per share. For the trailing twelve months ended August 31, 2026, revenue stood at $25.2M with a net profit margin of -1.7% and EPS of -$0.09. In the latest quarter ended August 31, 2026, revenue declined 12.7% year-over-year while quarterly earnings fell 88.5%.

ARTW income statement →

Balance sheet and cash flow

As of August 31, 2026, Art's-Way held $2,855 in cash and short-term investments alongside total debt of $6.5M, resulting in net debt of $6.5M. Total assets stood at $26.2M against shareholders' equity of $13.7M, yielding a debt-to-equity ratio of 0.48 and a current ratio of 1.71. Operating cash flow in FY2025 was -$904,143, and free cash flow was -$1.5M. For FY2025, cash usage included $627,615 in capital expenditures and $1,542 in share buybacks, while share count increased 14.8% over five years.

ARTW balance sheet →

Valuation and performance

At a share price of $3.17 and a market capitalization of $16.5M, Art's-Way trades at a forward P/E of 6.4x, which sits below the 17.2x median of its US-listed Industrials peers. Its price-to-sales multiple is 0.7x compared to the peer median of 1.5x, while EV/EBITDA stands at 16.5x versus the peer median of 13.9x. The stock has delivered a 1-year return of 20.3%, outperforming the S&P 500 (SPY) return of 16.8%, but its 5-year return of -6.9% trails the S&P 500 return of 83.0%.

ARTW key metrics →

What analysts expect

Analysts have established a mean price target of $7.00 for Art's-Way, which represents an upside of 121.2% above its last close of $3.17 on October 16, 2026. Forward valuation estimates place the forward P/E multiple at 6.4x with a PEG ratio of 2.77.

Key risks and what to watch

  • Liquidity risk is heightened by cash and short-term investments totaling just $2,855 alongside $6.5M in net debt.
  • Recent profitability trends are negative, reflected by a trailing twelve-month operating margin of -1.2% and EPS of -$0.09.
  • Top-line contraction continued into the quarter ended August 31, 2026, as quarterly revenue dropped 12.7% year-over-year.
  • Shareholder dilution has occurred over the long term, with share count rising 14.8% across the past five years.

AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer

About this ARTW AI stock analysis

This page is an AI-written research summary of Art's-Way Manufacturing Co., Inc. (ARTW). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: ARTW income statement, ARTW balance sheet, ARTW key metrics, ARTW chart. See the ARTW stock overview for the latest quote and news.

ARTW AI stock analysis FAQ

What was Art's-Way's revenue and net income in FY2025?

In FY2025, Art's-Way generated $23.0M in revenue, down 6.2% from the prior year, and earned net income of $1.0M, or $0.20 per share.

Does Art's-Way pay a dividend?

No, Art's-Way does not currently pay a dividend.

What is Art's-Way's debt and liquidity position?

As of August 31, 2026, the company held $2,855 in cash and short-term investments and $6.5M in total debt. Its current ratio stood at 1.71 and debt-to-equity was 0.48.

How does Art's-Way's valuation compare to its peers?

Art's-Way trades at a forward P/E of 6.4x and a price-to-sales ratio of 0.7x, compared to US-listed Industrials peer medians of 17.2x and 1.5x, respectively. However, its EV/EBITDA of 16.5x is higher than the peer median of 13.9x.

More Industrials AI stock analysis